HomeProductsBuilding BlocksHeterocyclic ScaffoldsPiperidinesPerhexiline
Chemical structure of CAS 6621-47-2

Perhexiline

CAS No.6621-47-2
MDL No.N/A
MFC19H35N
MW277.50
InChI KeyCYXKNKQEMFBLER-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Perhexiline is a piperidine derivative with cardiovascular activity.

CAS No.6621-47-2
Product NamePerhexiline

Biological Targets

CPT1B·CPT2·MTOR

Associated Conditions

diastolic heart failure·heart failure·hypertrophic cardiomyopathy·diabetic cardiomyopathy·cardiovascular disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Drugs and steatohepatitis.

Seminars in liver disease • Vol. 22, Issue 2 • 2002
PMID: 12016549DOI: 10.1055/s-2002-30106

Leustroducsin B activates nuclear factor-kappaB via the acidic sphingomyelinase pathway in human bone marrow-derived stromal cell line KM-102.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research • Vol. 22, Issue 3 • 2002
PMID: 12034042DOI: 10.1089/107999002753675776

Perhexiline toxicity related to citalopram use.

The Medical journal of Australia • Vol. 176, Issue 11 • 2002
PMID: 12064991DOI: 10.5694/j.1326-5377.2002.tb04558.x

Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady-state dose.

British journal of clinical pharmacology • Vol. 54, Issue 2 • 2002
PMID: 12207628PMC: PMC1874409DOI: 10.1046/j.1365-2125.2002.01618.x

Documentation